Buyer Name: Queen's University Belfast
Buyer Address: University Rd, Belfast, UKN06, BT7 1NN, United Kingdom
Contact Name: Shauna Ryan
Contact Email: procurement@qub.ac.uk
Buyer Name: Queen's University Belfast
Buyer Address: University Rd, Belfast, UKN06, BT7 1NN, United Kingdom
Contact Name: Shauna Ryan
Contact Email: procurement@qub.ac.uk
The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions. (Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000). The primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows. The proposed system must: • Provide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding. • Deliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments. • Support automation and high-throughput analysis, enabling efficient screening of large sample sets. • Include robust data analysis software for comprehensive kinetic modelling and data interpretation. • Offer versatile assay configurations, supporting various experimental formats and immobilisation chemistries. • Integrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis. The procurement of a high-performance SPR system directly supports FMI’s broader goals of: • Accelerating drug discovery through rapid identification and characterisation of therapeutic candidates. • Enhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development. • Facilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications. This procurement will provide direct benefit to research scientists by: • Reducing manual intervention and experimental variability through automation and streamlined workflows. • Enhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling. • Please note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. • No award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.
No linked documents found for this notice.
Lot 1 Status: complete
{
"awards": [
{
"aboveThreshold": true,
"assessmentSummariesDateSent": "2025-12-22T00:00:00+00:00",
"contractPeriod": {
"endDate": "2029-01-08T23:59:59+00:00",
"maxExtentDate": "2036-01-08T23:59:59+00:00",
"startDate": "2026-01-09T00:00:00+00:00"
},
"date": "2025-12-22T00:00:00+00:00",
"documents": [
{
"datePublished": "2025-12-22T19:27:33Z",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "085607-2025",
"noticeType": "UK6",
"url": "https://www.find-tender.service.gov.uk/Notice/085607-2025"
}
],
"hasRenewal": true,
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Detection and analysis apparatus",
"id": "38430000",
"scheme": "CPV"
},
{
"description": "Analysis apparatus",
"id": "38432000",
"scheme": "CPV"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"milestones": [
{
"dueDate": "2026-01-07T23:59:59+00:00",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"relatedLots": [
"1"
],
"renewal": {
"description": "option to extend maintenance, software \nupdates/development, the supply of consumables and ancillary items, beyond this \nperiod for a further period of up to 10 years or the end of useful life of the \nequipment."
},
"standstillPeriod": {
"endDate": "2026-01-06T23:59:59+00:00"
},
"status": "pending",
"suppliers": [
{
"id": "GB-PPON-PRYY-4533-ZMZR",
"name": "Global Life Sciences Solutions Operations UK Limited"
}
],
"value": {
"amountGross": 700000,
"currency": "GBP"
}
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "2",
"measure": "finalStageBids",
"relatedLot": "1",
"value": 1
},
{
"id": "3",
"measure": "smeFinalStageBids",
"relatedLot": "1",
"value": 0
},
{
"id": "4",
"measure": "vcseFinalStageBids",
"relatedLot": "1",
"value": 0
}
]
},
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen\u0027s University Belfast"
},
"date": "2025-12-22T19:27:33Z",
"id": "085607-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05cdd5",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"region": "UKN06",
"streetAddress": "University Rd"
},
"contactPoint": {
"email": "procurement@qub.ac.uk",
"name": "Shauna Ryan"
},
"details": {
"classifications": [
{
"description": "Public authority - sub-central government",
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE"
},
{
"description": "Northern Irish devolved regulations apply",
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS"
}
]
},
"id": "GB-NIC-101788",
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"name": "Queen\u0027s University Belfast",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Little Chalfont",
"postalCode": "HP7 9NA",
"region": "UKJ13",
"streetAddress": "Amersham Place"
},
"contactPoint": {
"email": "tendersukie@cytiva.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-PPON-PRYY-4533-ZMZR",
"identifier": {
"id": "PRYY-4533-ZMZR",
"scheme": "GB-PPON"
},
"name": "Global Life Sciences Solutions Operations UK Limited",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty \u0026 annual preventative maintenance is is \u00a3330,000).\nThe primary objective of procuring an SPR device is to enhance FMI\u2019s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n\u2022\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein\u2013protein, protein\u2013antibody, and protein\u2013small molecule binding.\n\u2022\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n\u2022\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n\u2022\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n\u2022\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n\u2022\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI\u2019s broader goals of:\n\u2022\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n\u2022\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n\u2022\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n\u2022\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n\u2022\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n\u2022\tPlease note: - The execution of this tender \u0026 contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n\u2022\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"id": "250262",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "complete",
"title": "250262 - Contract for Supply, Delivery, Installation \u0026 Commissioning of a Surface Plasmon Resonance (SPR) System."
}
}